Genomic Study Maps Shared Risk Factors for 14 Psychiatric Disorders
December 14, 2025
Background
Spinal metastases are considered as the most common tumors in the spine which involve approximately 90% of the spinal masses. Around 20% of the patients show symptoms of spinal cord compression where invasion of the spinal canal is also possible. They usually appear as bone metastases. It is mostly observed in the thoracic spine, the lumbar area and sometimes both whereas in cervical spine it is less prevalent.
The preservation of the intervertebral disc spaces which in contrast to infections that usually involve these gaps as it is taken as a crucial feature of spinal metastases on MRI.
Epidemiology
Research on post-mortem examinations of cancer patients has demonstrated that 70% to 90% of cases.Patients within breast and prostate cancer have found to be suffering from spinal metastases. The major consequences of spinal metastases are severe back pain which uses high doses of opioid medicine, pathological fractures of the bones, hypercalcemia and compression of the spinal cord because of epidural space invasion.
Anatomy
Pathophysiology
Metastases often spread into the bloodstream to the vertebral body. Tumor-related factors first interact with osteoclasts and other intrinsic bone cells to form an invasion nidus. The pedicles are frequently affected by posterior tumor dissemination which is important for the surgical therapy of spinal metastases that need stability. As a result the screw fixation via the affected pedicles is frequently inadequate which necessitates the union of numerous segments both above and below the lesion. Because pedicular arteries usually provide blood to the metastatic nidus, the targeted embolization is a feasible interventional strategy. The pharmacological therapy for the treatment of painful bone metastases especially in breast and prostate malignancies have been made possible by our growing understanding of the interactions between invasive metastases and surrounding bone cells as well as molecules like interleukin-1, IL-6 and RANK/RANKL.
Etiology
Cancers of the breast, prostate, lung, kidney, gastrointestinal, thyroid and other primary malignancies are the ones that metastasize to the spine most commonly. While spinal metastases are possible for any tumor, certain malignancies are more likely to occur at an early stage of the disease.
Genetics
Prognostic Factors
There is a ten-month median survival time for metastatic illness involving the spine which has a bad prognosis. The morbidity of cancer patients is usually high in the case of spinal metastases. The quality of a patient’s life is substantially reduced due to these consequences.
Clinical History
Age group: It is more prevalent in patients older than 60 years. Middle-aged individuals aged 40 to 60 also experience spinal metastases. Very rare cases affect the children where it is often associated with genetical abnormalities.
Physical Examination
Assess the pain and observe any spine deformities.
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Many of the patients initially present with back pain and bone pain. There are acute neurological impairments observed which require immediate attention and medical treatment must be provided.
Differential Diagnoses
Primary Bone Tumors
Spinal Infections
Degenerative Spine Conditions
Trauma
Herniated Disc
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-a-non-pharmacological-approach-for-treating-spinal-metastases
Role of Bisphosphonates in the treatment of spinal metastases
Role of Monoclonal Antibodies in the treatment of Spinal metastases
Denosumab: A monoclonal antibody known as denosumab targets a protein known as receptor activator of nuclear factor kappa-B ligand or RANKL.
Role of Corticosteroids
Dexamethasone: It is an effective corticosteroid with anti-inflammatory characteristics. It is frequently used to reduce the edema and relieve symptoms in the short-term therapy of spinal cord compression which is caused by metastatic lesions.
Role of Radiation Therapy
use-of-intervention-with-a-procedure-in-treating-spinal-metastases
use-of-phases-in-managing-spinal-metastases
Medication
Future Trends
Spinal metastases are considered as the most common tumors in the spine which involve approximately 90% of the spinal masses. Around 20% of the patients show symptoms of spinal cord compression where invasion of the spinal canal is also possible. They usually appear as bone metastases. It is mostly observed in the thoracic spine, the lumbar area and sometimes both whereas in cervical spine it is less prevalent.
The preservation of the intervertebral disc spaces which in contrast to infections that usually involve these gaps as it is taken as a crucial feature of spinal metastases on MRI.
Research on post-mortem examinations of cancer patients has demonstrated that 70% to 90% of cases.Patients within breast and prostate cancer have found to be suffering from spinal metastases. The major consequences of spinal metastases are severe back pain which uses high doses of opioid medicine, pathological fractures of the bones, hypercalcemia and compression of the spinal cord because of epidural space invasion.
Metastases often spread into the bloodstream to the vertebral body. Tumor-related factors first interact with osteoclasts and other intrinsic bone cells to form an invasion nidus. The pedicles are frequently affected by posterior tumor dissemination which is important for the surgical therapy of spinal metastases that need stability. As a result the screw fixation via the affected pedicles is frequently inadequate which necessitates the union of numerous segments both above and below the lesion. Because pedicular arteries usually provide blood to the metastatic nidus, the targeted embolization is a feasible interventional strategy. The pharmacological therapy for the treatment of painful bone metastases especially in breast and prostate malignancies have been made possible by our growing understanding of the interactions between invasive metastases and surrounding bone cells as well as molecules like interleukin-1, IL-6 and RANK/RANKL.
Cancers of the breast, prostate, lung, kidney, gastrointestinal, thyroid and other primary malignancies are the ones that metastasize to the spine most commonly. While spinal metastases are possible for any tumor, certain malignancies are more likely to occur at an early stage of the disease.
There is a ten-month median survival time for metastatic illness involving the spine which has a bad prognosis. The morbidity of cancer patients is usually high in the case of spinal metastases. The quality of a patient’s life is substantially reduced due to these consequences.
Age group: It is more prevalent in patients older than 60 years. Middle-aged individuals aged 40 to 60 also experience spinal metastases. Very rare cases affect the children where it is often associated with genetical abnormalities.
Assess the pain and observe any spine deformities.
Many of the patients initially present with back pain and bone pain. There are acute neurological impairments observed which require immediate attention and medical treatment must be provided.
Primary Bone Tumors
Spinal Infections
Degenerative Spine Conditions
Trauma
Herniated Disc
Allergy and Immunology
Anesthesiology
Cardiology, Echocardiography
Cardiology, Electrophysiology
Cardiology, General
Cardiology, Interventional
Cardiology, Nuclear
Critical Care/Intensive Care
Dermatology, General
Dermatology, Cosmetic
Diabetes
Diabetes Educator
Emergency Medicine
Endocrinology, Metabolism
Endocrinology, Reproductive/Infertility
Family Medicine
Gastroenterology
General Practice
Genomic Medicine
Geriatrics
Hematology
Hepatology
HIV/AIDS
Hospice/Palliative Medicine
Hospital Medicine
Infectious Disease
Internal Medicine
Neonatal/Perinatal Medicine
Nephrology
Neurology
Neurosurgery
Nuclear Medicine
Nutrition
OB/GYN and Women\'s Health
Oncology, Hematology/Oncology
Oncology, Medical
Oncology, Other
Oncology, Radiation
Ophthalmology
Orthopaedic Surgery
Otolaryngology
Pain Management
Pathology
Pediatrics, Allergy
Pediatrics, Cardiology
Pediatrics, General
Pediatrics, Oncology
Physical Medicine and Rehabilitation
Plastic Surgery and Anesthetic Medicine
Preventative Medicine
Psychiatry/Mental Health
Public/Community Health
Pulmonary Medicine
Radiology
Radiology, Interventional
Rheumatology
Surgery, Cardiothoracic
Surgery, General
Surgery, Oral and Maxillofacial
Surgery, Other
Surgery, Surgical Oncology
Surgery, Vascular
Transplantation
Urology
Vascular Medicine
Other Clinical
Non-Clinical
Oncology, Other
Oncology, Radiation
Denosumab: A monoclonal antibody known as denosumab targets a protein known as receptor activator of nuclear factor kappa-B ligand or RANKL.
Oncology, Radiation
Dexamethasone: It is an effective corticosteroid with anti-inflammatory characteristics. It is frequently used to reduce the edema and relieve symptoms in the short-term therapy of spinal cord compression which is caused by metastatic lesions.
Oncology, Radiation
Oncology, Radiation
Oncology, Radiation
Spinal metastases are considered as the most common tumors in the spine which involve approximately 90% of the spinal masses. Around 20% of the patients show symptoms of spinal cord compression where invasion of the spinal canal is also possible. They usually appear as bone metastases. It is mostly observed in the thoracic spine, the lumbar area and sometimes both whereas in cervical spine it is less prevalent.
The preservation of the intervertebral disc spaces which in contrast to infections that usually involve these gaps as it is taken as a crucial feature of spinal metastases on MRI.
Research on post-mortem examinations of cancer patients has demonstrated that 70% to 90% of cases.Patients within breast and prostate cancer have found to be suffering from spinal metastases. The major consequences of spinal metastases are severe back pain which uses high doses of opioid medicine, pathological fractures of the bones, hypercalcemia and compression of the spinal cord because of epidural space invasion.
Metastases often spread into the bloodstream to the vertebral body. Tumor-related factors first interact with osteoclasts and other intrinsic bone cells to form an invasion nidus. The pedicles are frequently affected by posterior tumor dissemination which is important for the surgical therapy of spinal metastases that need stability. As a result the screw fixation via the affected pedicles is frequently inadequate which necessitates the union of numerous segments both above and below the lesion. Because pedicular arteries usually provide blood to the metastatic nidus, the targeted embolization is a feasible interventional strategy. The pharmacological therapy for the treatment of painful bone metastases especially in breast and prostate malignancies have been made possible by our growing understanding of the interactions between invasive metastases and surrounding bone cells as well as molecules like interleukin-1, IL-6 and RANK/RANKL.
Cancers of the breast, prostate, lung, kidney, gastrointestinal, thyroid and other primary malignancies are the ones that metastasize to the spine most commonly. While spinal metastases are possible for any tumor, certain malignancies are more likely to occur at an early stage of the disease.
There is a ten-month median survival time for metastatic illness involving the spine which has a bad prognosis. The morbidity of cancer patients is usually high in the case of spinal metastases. The quality of a patient’s life is substantially reduced due to these consequences.
Age group: It is more prevalent in patients older than 60 years. Middle-aged individuals aged 40 to 60 also experience spinal metastases. Very rare cases affect the children where it is often associated with genetical abnormalities.
Assess the pain and observe any spine deformities.
Many of the patients initially present with back pain and bone pain. There are acute neurological impairments observed which require immediate attention and medical treatment must be provided.
Primary Bone Tumors
Spinal Infections
Degenerative Spine Conditions
Trauma
Herniated Disc
Allergy and Immunology
Anesthesiology
Cardiology, Echocardiography
Cardiology, Electrophysiology
Cardiology, General
Cardiology, Interventional
Cardiology, Nuclear
Critical Care/Intensive Care
Dermatology, General
Dermatology, Cosmetic
Diabetes
Diabetes Educator
Emergency Medicine
Endocrinology, Metabolism
Endocrinology, Reproductive/Infertility
Family Medicine
Gastroenterology
General Practice
Genomic Medicine
Geriatrics
Hematology
Hepatology
HIV/AIDS
Hospice/Palliative Medicine
Hospital Medicine
Infectious Disease
Internal Medicine
Neonatal/Perinatal Medicine
Nephrology
Neurology
Neurosurgery
Nuclear Medicine
Nutrition
OB/GYN and Women\'s Health
Oncology, Hematology/Oncology
Oncology, Medical
Oncology, Other
Oncology, Radiation
Ophthalmology
Orthopaedic Surgery
Otolaryngology
Pain Management
Pathology
Pediatrics, Allergy
Pediatrics, Cardiology
Pediatrics, General
Pediatrics, Oncology
Physical Medicine and Rehabilitation
Plastic Surgery and Anesthetic Medicine
Preventative Medicine
Psychiatry/Mental Health
Public/Community Health
Pulmonary Medicine
Radiology
Radiology, Interventional
Rheumatology
Surgery, Cardiothoracic
Surgery, General
Surgery, Oral and Maxillofacial
Surgery, Other
Surgery, Surgical Oncology
Surgery, Vascular
Transplantation
Urology
Vascular Medicine
Other Clinical
Non-Clinical
Oncology, Other
Oncology, Radiation
Denosumab: A monoclonal antibody known as denosumab targets a protein known as receptor activator of nuclear factor kappa-B ligand or RANKL.
Oncology, Radiation
Dexamethasone: It is an effective corticosteroid with anti-inflammatory characteristics. It is frequently used to reduce the edema and relieve symptoms in the short-term therapy of spinal cord compression which is caused by metastatic lesions.
Oncology, Radiation
Oncology, Radiation
Oncology, Radiation

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
